Urgent Call for Enhanced Breast Cancer Africa Control Measures

By Crystal Lubbe

February 19, 2025

The article from the World Health Organization (WHO) Regional Office for Africa, titled “Urgent action needed to reinforce breast cancer control measures in Africa: WHO report,” highlights critical issues and recommendations regarding breast cancer in Africa. This report brings attention to the urgent need for improved control measures to combat the rising burden of the disease across the continent.

Breast Cancer Burden

The report estimates that if current trends continue, approximately 135,000 women in sub-Saharan Africa could lose their lives to breast cancer by 2040. The WHO study assessed breast cancer control capacities in 42 out of the 47 countries in the African region. It focused on six vital areas: leadership, governance and financing, health workforce, health information systems, and service delivery. Africa faces significant gaps and disparities in breast cancer control, with critical challenges affecting prevention, diagnosis, and treatment. A severe shortage of healthcare workers limits essential services, while access to specialised cancer centers remains inadequate. Only 5 out of 47 countries have organised breast cancer screening programs, forcing most to rely on opportunistic screening. Pathology services are also insufficient, with only two countries meeting the standard of one laboratory per 100,000 people. These gaps hinder early detection and effective treatment, contributing to high mortality rates.

Drivers of Breast Cancer-Related Deaths

Late diagnoses and poor prevention efforts drive high breast cancer mortality. In 2022, Africa recorded 38 new cases and 19 deaths per 100,000 women. The report calls for urgent investments in leadership, governance, and financing to improve breast cancer care. Countries must develop and fund National Cancer Control Plans for coordinated action. Expanding oncology training is crucial to address the severe shortage of cancer professionals. Organised screening and early diagnosis programs must be accessible to all women, as early detection greatly improves survival rates. A multi-faceted approach is essential to strengthen healthcare infrastructure, train more professionals, and ensure equitable access to life-saving services.

Reference url

Recent Posts

oral health Africa
    

Oral Health in Africa: Promoting Collaborative Solutions

🦷 Is oral health taking a back seat in public health discussions in Africa?

A new article reveals alarming statistics about the high prevalence of untreated dental diseases across the continent and a critical shortage of oral health professionals. It emphasizes the urgent need for collaborative action among healthcare providers and policy-makers to integrate oral health into broader public health frameworks.

Discover how strengthening partnerships can pave the way for improved health outcomes and resource allocation in oral health.

#SyenzaNews #globalhealth #HealthEconomics

tislelizumab NSCLC treatment
        

Early Benefit Assessment of Tislelizumab NSCLC Treatment: Insights and Implications

🧐 How is the evolving treatment landscape for NSCLC affecting patient access to tislelizumab?

The German Federal Joint Committee (G-BA) has launched an early benefit assessment for tislelizumab as a second-line treatment for adults with advanced NSCLC. This assessment notably focuses on PD-L1 negative patients and highlights the need for additional data to substantiate its value amidst a shifting emphasis on first-line immunotherapy.

Explore the nuances of this assessment and its implications for future research and market access in the full article.

#SyenzaNews #oncology #MarketAccess

colorectal cancer screening
    

Advances in Colorectal Cancer Screening: Access and Cost

🚀 Is blood-based screening redefining colorectal cancer detection?

The Shield blood test offers a non-invasive alternative to colonoscopy—boosting screening uptake, but raising questions around effectiveness and value.

🔍 Discover how this innovation could reshape patient care, payer strategy, and health system costs.

#SyenzaNews #HealthcareInnovation #CostEffectiveness #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.